The Diabetic Kidney Disease market report covers emerging drugs, current treatment practices, Diabetic Kidney Disease market share of the individual therapies, current and forecasted Diabetic Kidney Disease Market Size from 2017 to 2030 segmented by seven major markets.
The report also provides detailed current Diabetic Kidney Disease treatment practice/algorithm, market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses the underlying potential of the market.
Diabetic Kidney Disease Market Key Facts
According to the National Institute of Diabetes and Digestive and Kidney Disease, diabetes is the leading cause of kidney disease and about one out of four adults with diabetes have kidney disease.
As per the study by Li et al. titled “Prevalence of Diabetes and Diabetic Nephropathy in a Large U.S. Commercially Insured Pediatric Population, 2002–2013,” the annual prevalence of diabetic nephropathy in pediatric patients with diabetes increased from 1.16 to 3.44% for all cases and 0.83 to 2.32% for probable cases only in 2002–2013. Prevalence of diabetes and diabetic nephropathy was highest in patients aged 12 to
Through various secondary domains, it can be anticipated that there is not much difference in the epidemiology of DKD based on gender, however, there is a slight tilt towards the female population
Visit For Sample Pages:
Key Benefits of Diabetic Kidney Disease Market Report
Diabetic Kidney Disease market report provides an in-depth analysis of Diabetic Kidney Disease Market Size, Share, Trend, Epidemiology and Market Forecast till 2030, in 7 major market i.e. EU5 (Germany, Italy, Spain, France and the UK), Japan, and the United States.
The Diabetic Kidney Disease market report will help in developing business strategies by understanding the Diabetic Kidney Disease Market trends & developments, key players and future market competition that will shape and drive the Diabetic Kidney Disease market in the upcoming years.
The Diabetic Kidney Disease market report covers Diabetic Kidney Disease current treatment practices, emerging drugs, market share of the individual therapies in 7 MM.
The report provides a detailed assessment of the Diabetic Kidney Disease market in terms of market drivers & barriers, Unmet Needs, market opportunities, patient population, comparative analysis of pipeline products with detailed clinical profiles, and other factors.
The Diabetic Kidney Disease market outlook section of the report helps to build the detailed comprehension of the historic, current and forecasted Diabetic Kidney Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology.
The report gives a thorough detail of Diabetic Kidney Disease market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders.
The Diabetic Kidney Disease epidemiology section covers insights about historical and current Diabetic Kidney Disease patient pool and forecasted trend for every seven major countries (i.e. the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom), and Japan from 2017 to 2030.
It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.
Diabetic Kidney Disease Drugs Uptake section focuses on the rate of uptake of the potential drugs recently launched in the Diabetic Kidney Disease market or expected to get launched in the market during the study period. The analysis covers Diabetic Kidney Disease market uptake by drugs; patient uptake by therapies; and sales of each drug.
Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.
Some of the Emerging Drugs in Diabetic Kidney Disease (DKD) market include Finerenone (BAY94–8862), Selonsertib (SEL), Fenofibrate, LMB763, Bardoxolone methyl and many others.
Key companies in Diabetic Kidney Disease (DKD) market include Bayer, Gilead Science, Kyowa Kirin, Mylan, Novartis and others.
Table of Content
1. Key Insights
2. Executive Summary
3. Diabetic Kidney Disease Competitive Intelligence Analysis
4. Diabetic Kidney Disease Market Overview at a Glance
5. Diabetic Kidney Disease Disease Background and Overview
6. Diabetic Kidney Disease Patient Journey
7. Diabetic Kidney Disease Epidemiology and Patient Population
8. Diabetic Kidney Disease Treatment Algorithm, Current Treatment, and Medical Practices
9. Diabetic Kidney Disease Unmet Needs
10. Key Endpoints of Diabetic Kidney Disease Treatment
11. Diabetic Kidney Disease Marketed Products
12. Diabetic Kidney Disease Emerging Therapies
13. Diabetic Kidney Disease Seven Major Market Analysis
14. Attribute Analysis
15. Diabetic Kidney Disease Market Outlook (7 major markets)
16. Diabetic Kidney Disease Access and Reimbursement Overview
17. KOL Views on the Diabetic Kidney Disease Market.
18. Diabetic Kidney Disease Market Drivers
19. Diabetic Kidney Disease Market Barriers
21. DelveInsight Capabilities
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.
Company Name: DelveInsight Business Research LLP
Contact Person: Anuj Rawat
Email: Send Email
Address:304 S. Jones Blvd #2432
State: New York
Country: United States